Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the “atypical” category and an increase in its prediction of subsequent high‐grade urothelial carcinoma

Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of... INTRODUCTIONUrine cytology is an essential method for the surveillance and detection of urothelial neoplasms, with its strength being its specificity for the detection of high‐grade urothelial carcinoma (HGUC). In 2004, the Papanicolaou Society of Cytopathology developed a urine cytology classification scheme that included a category of “atypical urothelial cells” (AUC) and further subclassified this atypical group into reactive or neoplastic. However, this classification scheme was lacking in specific and reproducible criteria for the recommended atypical categories. To meet this need, various institutions independently developed in‐house diagnostic criteria as well as subclassifications for the “atypical” category, such as “AUCs favor a reactive process versus AUCs unclear whether reactive or neoplastic,” “AUCs of undetermined significance versus AUCs‐cannot rule out high‐grade carcinoma,” and “AUCs favor a reactive process versus AUCs favor neoplastic.” The wide variation in the use and criteria for the atypical category resulted in significant differences in the interinstitutional rates of the AUC diagnosis (range, 2%‐31%), as well as its association with subsequent histologic diagnoses of HGUC (range, 8.3%‐37.5%). The unpredictable nature of the atypical category contributed to the inclination of many urologists to treat AUC cases similarly to “negative” cases, thereby rendering it a clinically irrelevant diagnostic category.It is http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cancer Cytopathology Wiley

Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the “atypical” category and an increase in its prediction of subsequent high‐grade urothelial carcinoma

Loading next page...
 
/lp/wiley/implementing-the-paris-system-for-reporting-urinary-cytology-results-U5h9pIad9X
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 American Cancer Society
ISSN
1934-662X
eISSN
1934-6638
D.O.I.
10.1002/cncy.21958
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONUrine cytology is an essential method for the surveillance and detection of urothelial neoplasms, with its strength being its specificity for the detection of high‐grade urothelial carcinoma (HGUC). In 2004, the Papanicolaou Society of Cytopathology developed a urine cytology classification scheme that included a category of “atypical urothelial cells” (AUC) and further subclassified this atypical group into reactive or neoplastic. However, this classification scheme was lacking in specific and reproducible criteria for the recommended atypical categories. To meet this need, various institutions independently developed in‐house diagnostic criteria as well as subclassifications for the “atypical” category, such as “AUCs favor a reactive process versus AUCs unclear whether reactive or neoplastic,” “AUCs of undetermined significance versus AUCs‐cannot rule out high‐grade carcinoma,” and “AUCs favor a reactive process versus AUCs favor neoplastic.” The wide variation in the use and criteria for the atypical category resulted in significant differences in the interinstitutional rates of the AUC diagnosis (range, 2%‐31%), as well as its association with subsequent histologic diagnoses of HGUC (range, 8.3%‐37.5%). The unpredictable nature of the atypical category contributed to the inclination of many urologists to treat AUC cases similarly to “negative” cases, thereby rendering it a clinically irrelevant diagnostic category.It is

Journal

Cancer CytopathologyWiley

Published: Jan 1, 2018

Keywords: ; ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial